Bristol-Myers Squibb Company (BMY) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2026
Loading P/E history...
BMY Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Bristol-Myers Squibb Company (BMY) trades at a price-to-earnings ratio of 16.4x, with a stock price of $56.54 and trailing twelve-month earnings per share of $3.56.
The current P/E is 24% below its 5-year average of 21.5x. Over the past five years, BMY's P/E has ranged from a low of 11.9x to a high of 68.8x, placing the current valuation at the 35th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, BMY trades at a 26% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, BMY trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BMY DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BMY P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $151B | 19.5 | - | -4% | |
| $280B | 15.6 | 0.73 | +8% | |
| $363B | 86.5 | - | -1% | |
| $933B | 43.0 | 1.49 | +96% | |
| $541B | 38.8 | - | -58% | |
| $287B | 28.3 | 1.30 | +191% | |
| $102B | 6.7Lowest | 0.47Best | +348%Best | |
| $170B | 358.7 | - | -92% | |
| $75B | 17.4 | 2.75 | +8% | |
| $106B | 18.4 | - | -7% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
BMY Historical P/E Data (1990–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $60.65 | $3.56 | 17.0x | -36% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $53.94 | $3.45 | 15.6x | -41% |
| FY2025 Q3 | $45.10 | $2.96 | 15.3x | -43% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $46.29 | $2.48 | 18.7x | -30% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $60.99 | $2.67 | 22.9x | -14% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $51.31 | $3.86 | 13.3x | -50% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $58.04 | $3.94 | 14.7x | -45% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $63.95 | $3.76 | 17.0x | -36% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $69.31 | $3.43 | 20.2x | -24% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $71.95 | $2.95 | 24.4x | -8% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $71.09 | $3.07 | 23.2x | -13% |
| FY2022 Q2 | $77.00 | $3.01 | 25.6x | -4% |
Average P/E for displayed period: 26.6x
Full BMY Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BMY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BMY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BMY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBMY — Frequently Asked Questions
Quick answers to the most common questions about buying BMY stock.
Is BMY stock overvalued or undervalued?
BMY trades at 16.4x P/E, below its 5-year average of 21.5x. At the 35th percentile of historical range, the stock is priced at a discount to its own history.
How does BMY's valuation compare to peers?
Bristol-Myers Squibb Company P/E of 16.4x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is BMY's PEG ratio?
BMY PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2026.